Oncology Update Episode 7 by LucidQuest скачать в хорошем качестве

Oncology Update Episode 7 by LucidQuest

🧬✨ Dive into this week’s top breakthroughs in oncology — from global approvals to strategic pivots and pipeline milestones across multiple cancer types. In this episode of Oncology Updates by LucidQuest, we spotlight regulatory wins, pivotal clinical trial data, and high-impact collaborations shaping the future of cancer care. Whether you're tracking developments in lung, gastric, breast, prostate, ovarian, renal, or cervical cancer, this roundup delivers the insights that matter most. 🌍🔥 Key Highlights: 🫁 Imfinzi approved in the EU for limited-stage small cell lung cancer — 27% reduction in risk of death 💉 FDA grants full approval to pembrolizumab combo for HER2-positive, PD-L1-positive gastric/GEJ cancer 🏅 HLX22 receives Orphan Drug Designation in the U.S. for HER2-positive gastric cancer ⚠️ Elevation Oncology discontinues EO-3021 and shifts to HER3 ADC, with IND filing expected in 2026 🇯🇵 Datroway becomes Japan’s first TROP2-targeted therapy for HR-positive, HER2-negative breast cancer 🧪 Fruquintinib + sintilimab meet primary endpoint in advanced renal cell carcinoma 🧬 CAN-2409 shows strong efficacy in prostate cancer with greater than 80 percent complete response 🎯 Cadonilimab + chemoradiotherapy achieves 100% objective response rate in locally advanced cervical cancer 🌸 JSKN003 earns Breakthrough Therapy status for platinum-resistant ovarian cancer, HER2 status independent 🤝 Oxford BioTherapeutics and Roche sign ADC discovery deal targeting solid tumors 💊 AstraZeneca partners with Alteogen to develop subcutaneous oncology drug delivery 📢 Stay Ahead in Oncology Research! ✅ Like, share, and subscribe for weekly updates on oncology and cancer innovation ✅ Visit www.lqventures.com for expert healthcare insights and consulting services ✅ Contact LucidQuest at info@lqventures.com for strategic guidance on oncology innovations and clinical research 🔔 Turn on notifications so you never miss an update! #OncologyUpdates #CancerResearch #FDAApproval #Immunotherapy #OncologyPipeline #SolidTumors #ClinicalTrials #BiotechNews #OncologyBreakthroughs #LucidQuest #ADC #CancerTreatment #LungCancer #GastricCancer #BreastCancer #ProstateCancer #RenalCancer #OvarianCancer #CervicalCancer